DE000A2GS5D8
DE000A2GS5D8
Dermapharm Holding SE I
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.9B EUR | 2.34B EUR | 2.28B EUR | 2.12B EUR |
Enterprise Value | 2.87B EUR | 3.31B EUR | 2.05B EUR | 2.97B EUR |
Valuation Multiples | ||||
Trailing P/E | 14.07x | 15.94x | 15.79x | 21.4x |
Forward P/E | 12.94x | -- | -- | -- |
Price to Sales | 1.61x | 1.98x | 1.95x | 2.46x |
Price to Book | 3.54x | 4.35x | 3.08x | 3.05x |
EV/Revenue | 2.43x | 2.8x | 1.76x | 3.44x |
EV/EBITDA | 9.26x | 8.37x | 6.09x | 12.15x |
Price to FCF (P/FCF) | 12.3x | 10.82x | 9.46x | 10.98x |
EV/FCF | 18.54x | 15.32x | 8.52x | 15.39x |
FCF Yield | 8.13% | 9.25% | 10.58% | 9.1% |